Stock Alert: Maravai LifeSciences Holdings - Company Will Delay Earnings Release - Kehoe Law Firm, P.C. Investigating Potential Securities Claims - MRVI

Philadelphia, Pennsylvania--(Newsfile Corp. - February 26, 2025) - Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of Maravai LifeSciences Holdings, Inc. ("Maravai LifeSciences," "Maravai," or the "Company") (NASDAQ: MRVI) investors.

INVESTORS OF MARAVAI LIFESCIENCES STOCK ARE ENCOURAGED TO COMPLETE KLF'S SECURITIES QUESTIONNAIRE OR SEND US A MESSAGE TO REACH AN ATTORNEY FOR A FREE, NO-OBLIGATION LEGAL EVALUATION OF POTENTIAL CLAIMS.

Securities Questionnaire: https://kehoelawfirm.com/securities-questionnaire/
Contact Form: https://kehoelawfirm.com/contact/

On February 25, 2025, Maravai LifeSciences announced that it is postponing its previously announced earnings release and call scheduled for February 25, 2025, as well as that it intends to file a Form 12b-25, Notification of Late Filing, with the SEC and will delay the filing its annual report on Form 10-K for the fiscal year ended December 31, 2024.

Maravai LifeSciences also reported that it ". . . requires additional time to complete its year-end financial close process for reasons related primarily to the following items. First, Maravai requires additional time to complete its assessment of a potential non-cash impairment charge related to goodwill associated with its previous acquisition of Alphazyme LLC. Second, Maravai requires additional time to assess an error identified during the close process with respect to revenue recognition associated with a single shipment identified in year-end audit procedures that resulted in approximately $3.9 million in revenue being recorded in the final week of the second quarter of 2024 upon shipment when it should have been recorded in the first week of the third quarter of 2024 upon receipt by the customer."

Maravai's stock price dropped more than 20% by the close of trading on February 25, 2025.

Maravai LifeSciences Investors: Learn More About the Securities Investigation and Your Legal Options

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a plaintiff-side class action firm, fiercely committed to safeguarding investors and consumers from corporate fraud and misconduct. Nationally recognized, our attorneys have taken the reins as Lead or Co-Lead Counsel in high-profile cases, securing over $10 billion in recoveries for institutional and individual investors and consumers. Through relentless class action litigation, we tackle securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations head-on. Beyond that, we champion whistleblowers and fight against data breaches, consumer scams, employment law abuses, retirement plan mismanagement, and deceptive business practices. With a no-nonsense, results-focused approach, we chase down meaningful outcomes-delivering justice and substantial recoveries for those we represent.

This press release may constitute attorney advertising.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/242467